3-Position Biaryl Endochin-like Quinolones with Enhanced Antimalarial Performance.
antimalarial drug
next-generation ELQs
oral prophylaxis
structure−activity relationships
Journal
ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580
Informations de publication
Date de publication:
11 Jun 2024
11 Jun 2024
Historique:
medline:
12
6
2024
pubmed:
12
6
2024
entrez:
11
6
2024
Statut:
aheadofprint
Résumé
ELQ-300 is a potent antimalarial drug with activity against blood, liver, and vector stages of the disease. A prodrug,
Identifiants
pubmed: 38862127
doi: 10.1021/acsinfecdis.4c00140
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM